Person:
BABACAN YILDIZ, GÜLSEN

Loading...
Profile Picture
Google ScholarScopusORCIDPublons
Status
Kurumdan Ayrılmıştır
Organizational Units
Organizational Unit
Job Title
First Name
GÜLSEN
Last Name
BABACAN YILDIZ
Name
Email Address
Birth Date

Search Results

Now showing 1 - 10 of 10
  • PublicationOpen Access
    Cardiac safety of donepezil in elderly patients with Alzheimer disease
    (2012-01-01T00:00:00Z) Isik, AT; Yildiz, GÜLSEN; Bozoglu, E; Yay, A; Aydemir, E; BABACAN YILDIZ, GÜLSEN
    Objective Donepezil is a widely used cholinesterase inhibitor for the treatment of Alzheimer's disease (AD), however its cholinergic adverse side effects on the cardiovascular system are still unclear. In this study, we aimed to examine the adverse side effects caused by donepezil on cardiac rhythm and postural blood pressure changes in elderly patients with Alzheimer Disease. Methods The ECG parameters including heart rate, PR, QT, QTc interval and QRS duration and postural blood pressure changes were recorded at the baseline and at each donepezil dose level (5 and 10 mg/d). Patients Seventy-one consecutive patients who were referred by primary care centers to a Geriatric Clinic were enrolled and underwent comprehensive geriatric assessment. Results Fifty-two subjects completed the study. There were no significant changes relative to the baseline in any of the ECG parameters or arterial blood pressure at any of the investigated dosages of donepezil. Conclusion It was demonstrated that donepezil was not associated with increased negative chronotropic, arrhythmogenic or hypotensive effects for elderly patients with Alzheimer's disease.
  • PublicationOpen Access
    Motor and Non-Motor Symptoms in Parkinson-s Disease: Effects on Quality of Life.
    (2017-06-01) GÖKÇAL, ELİF; GÜR, VE; SELVITOP, R; Babacan, Yildiz; ASIL, TALİP; GÖKÇAL, ELİF; BABACAN YILDIZ, GÜLSEN; ASİL, TALIP
    Introduction: This study aimed to evaluate motor and non-motor symptoms in idiopathic Parkinson's disease (IPD) patients and to determine the self-reported influence of all existing symptoms on their quality of life (QoL). Methods: The sociodemographic and clinical characteristics, medical treatments, and Modified Hoehn and Yahr (mH&Y) scores of IPD patients without cognitive impairment were recorded. A survey questioning different motor and non-motor symptoms was administered to the patients. The patients were asked to rate their symptoms by number from the greatest influence to the least influence on their QoL. Subjects were divided into two groups: those suffering from IPD for ≤5 years (Group 1) and those suffering from IPD for >5 years (Group 2). These groups were compared in terms of sociodemographic and clinical characteristics, existing symptoms, and influences of these symptoms on their QoL. Results: There were 63 patients in Group 1 and 37 patients in Group 2. No statistically significant differences were detected between the groups with respect to sociodemographic characteristics or mH&Y scores. The most common motor symptoms in both of these groups were tremor and bradykinesia; meanwhile, the non-motor symptoms most frequently encountered in these groups were pain-cramps, constipation, and excessive daytime sleepiness (EDS). Again, while the symptoms that most greatly disturbed QoL in all patients were reported to be tremor and bradykinesia, the most disturbing non-motor symptom was frequent voiding/incontinence, which was a less common symptom. Pain-cramp, constipation, and EDS, which were the most frequent non-motor symptoms, were the symptoms that least disturbed QoL. Conclusion: It is widely accepted that motor symptoms determine QoL in IPD. However, non-motor symptoms are seen during all phases of the disease. The impact of non-motor symptoms on the QoL of IPD patients remains substantial. Therefore, in addition to the well-known motor symptoms, non-motor symptoms, which may be overlooked during physical examination yet may profoundly impact QoL, should be questioned and treated appropriately to improve QoL in PD patients as much as possible.
  • PublicationOpen Access
    Investigation of the Effects of Biochemical Parameters on Alzheimer-s Disease.
    (2019-07-16) Toprak, A; Gokce, MUSTAFA; Bektay, MUHAMMED YUNUS; Selvitop, R; Yildiz, GB; GÖKÇE, MUSTAFA; BEKTAY, MUHAMMED YUNUS; TOPRAK, ALİ; BABACAN YILDIZ, GÜLSEN
  • PublicationOpen Access
    Relationship between electrodiagnostic severity and neuropathic pain assessed by the LANSS pain scale in carpal tunnel syndrome.
    (2013-01-01T00:00:00Z) KOLUKISA, MEHMET; Gürsoy, AZİZE ESRA; YıLDıZ, GB; KOCAMAN, G; CELEBI, A; KOÇER, A; GÜRSOY, AZIZE ESRA; KOLUKISA, MEHMET; BABACAN YILDIZ, GÜLSEN
    Objective: The aim of the study was to investigate the relationship between the presence of neuropathic pain assessed by the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scale and electrophysiological findings in patients with carpal tunnel syndrome (CTS). Methods: We studied 124 hands with idiopathic CTS with pain complaints involving hand and wrist. All hands were assessed by the LANSS with which a score of 12 or more is defined as pain dominated by neuropathic mechanisms. These hands were assigned to minimal, mild, moderate, severe, or extreme severe groups according to the results of the median nerve conduction studies. Results: A LANSS score $ 12, suggestive of pain dominated by neuropathic mechanisms, was defined in 59 (47.6%) CTS hands. Pain intensity was significantly higher in CTS hands with a LANSS score $ 12 (P , 0.001). Among electrophysiological findings, compound muscle action potential amplitude was significantly lower in hands with a LANSS score $ 12 compared with hands with a LANSS score , 12 (P = 0.020). Severity of CTS was not significantly different between LANSS $ 12 and LANSS , 12 groups. Electrophysiological severity was significantly higher in CTS hands with evoked pain (P = 0.005) and allodynia (P , 0.001) in LANSS subscore analysis. Conclusion: We suggest that the presence of pain dominated by neuropathic mechanisms in CTS is not related to electrophysiological CTS severity. Neuropathic pain should be assessed carefully in patients with CTS, and an appropriate treatment plan should be chosen, taking into account the clinical and electrophysiological findings together with the true pain classification. Keywords: electrodiagnostic evaluation, carpal tunnel syndrome, LANSS, neuropathic pain
  • PublicationOpen Access
    Association between etiology and lesion site in ischemic brainstem infarcts: a retrospective observational study.
    (2018-03-13) BARAN, GÖZDE; GULTEKIN, TO; BARAN, O; DENIZ, C; KATAR, SELAHATTİN; Yildiz, GÜLSEN; ASIL, TALİP; BARAN, GÖZDE; DENİZ, ÇİĞDEM; KATAR, SELAHATTİN; BABACAN YILDIZ, GÜLSEN; ASİL, TALIP
    Background and purpose: To assess the anatomical distribution of the ischemic strokes of the brainstem, the effect of anatomical distribution on clinical features and prognosis, and the association between etiology and anatomical involvement. Methods: A retrospective search of the patient database of our institution was performed for a total of 227 patients who were admitted to the Department of Neurology, Medical Faculty of Bezmialem Vakif University between January 2012 and September 2014. Patients with adequate diagnostic data and 3-month follow-up visit were included in the study. Results: Twenty-one (9%), 136 (60%), and 65 (29%) patients had an infarction only at the mesencephalon, pons, and medulla, respectively. However, a single patient (0.5%) had an infarction both at the mesencephalon and pons, 3 (1.5%) at the pons and medulla, and 1 (0.5%) at the mesencephalon, pons, and medulla. While anterior involvement was more common in the mesencephalon and pons, posterior and lateral involvement occurred more frequently in the medulla. Large arterial atherothrombosis was the predominant cause of the strokes in all anatomical sites, particularly in infarcts involving the pons. Cardioembolic events were more common in patients with mesencephalic infarcts. Also, ischemia due to dissection was more common in infarctions involving the medulla, especially the lateral medulla. In subjects with simultaneous infarcts at other sites in addition to the brainstem, there was a significantly higher co-occurrence of medullary infarcts with cerebellar infarcts, mesencephalic infarcts with posterior cerebral artery infarcts, and pons infarcts with anterior circulation and multiple infarcts. Conclusion: Determination of risk factors and infarct localization as well as prediction of etiological parameters may assist in improving survival rates and therapeutic approaches.
  • PublicationOpen Access
    Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders.
    (2019-10-01T00:00:00Z) Ayer, AH; Wojta, K; Ramos, EM; Dokuru, D; Chen, JA; Karydas, AM; Papatriantafyllou, JD; Agiomyrgiannakis, D; Kamtsadeli, V; Tsinia, N; Sali, D; Gylys, KH; Agosta, F; Filippi, M; Small, GW; Bennett, DA; Gearing, M; Juncos, JL; Kramer, J; Lee, SE; Yokoyama, JS; Mendez, MF; Chui, H; Zarow, C; Ringman, JM; Kilic, U; Babacan-Yildiz, GÜLSEN; Levey, A; DeCarli, CS; Cotman, CW; Boxer, AL; Miller, BL; Coppola, G; BABACAN YILDIZ, GÜLSEN
  • PublicationOpen Access
    Distribution Patterns and Publishing Rates of Oral Presentations Presented in National Neurology Congresses According to Diseases Between 2000-2017
    (2020-12-01T00:00:00Z) Uslu, Ferda; Bayrakoğlu, Alişan; Meşe, Sultan; Babacan Yıldız, Gülsen; USLU, FERDA; BAYRAKOĞLU, ALİŞAN; MEŞE, SULTAN; BABACAN YILDIZ, GÜLSEN
    Objective: Congresses are important for physicians to access up-to-date information. The papers presented in congresses provide access to current research topics in the field in a short time. In this study, we aimed to investigate the contribution of oral presentations (OP) that were presented at the Turkish National Neurology Congress (TNNC) organized by the Turkish Neurological Society to the literature. Materials and Methods: OP presented in TNNCs between 2000-2017 were reviewed. The distribution of papers in terms of the main headings and their institutions were determined. Then, the names and presentation titles of the researchers were searched in PubMed and Google Scholar databases in Turkish and English and their publication rates were determined. Results: In 17 years, a total of 1682 oral and 8065 poster presentations were accepted. Fourteen OPs were withdrawn. Of the OPs, 318 were in the field of demyelinating diseases (DMD), 305 on cerebrovascular diseases (CVD), 205 on epilepsy, 202 on neuromuscular diseases (NMD), 199 on headache, 183 on movement disorders, 112 on behavioral neurology, 20 on sleep disorders, 13 on pediatric neurology, and 119 on other diseases. Of the studies, 1253 were clinical studies, 226 were case reports, 130 were basic science studies, 84 were questionnaire studies, 70 were genetic studies, and 852 were prospective studies. One thousand two hundred eighty-six were from university hospitals and 338 from training and research hospitals. Six hundred six were published as articles. One hundred seventy-one were published in Turkish journals and 416 were published in SCI-E journals. Of the publications, 481 were presentations from university hospitals. Comparing the 2000-2009 and 2010-2017 presentations, presentations of NMD and sleep disorders increased, and the highest number of presentations were in the CVD and DMD groups in both periods. Presentations of headache and epilepsy were mostly published in journals. Conclusion: To our knowledge, our study is the first to analyze neurology congress presentations in Turkey. It is noted that such analyses are performed in the literature mostly for 1-5 years, and our results are similar to those of other disciplinary studies conducted in our country and lower than those of international meetings. Incentive methods should be developed to increase the number of publications. Keywords: National neurology congress, congress analysis, verbal presentation, publication rate
  • PublicationOpen Access
    Asymmetric Blepharospasm Treated with Botulinum Toxin-A: Case Report
    (2019-01-01T00:00:00Z) Baran, Gozde; Deniz, Cigdem; GÜRSOY, Azize Esra; BABACAN YILDIZ, GÜLSEN; DENİZ, ÇİĞDEM; GÜRSOY, AZIZE ESRA; BABACAN YILDIZ, GÜLSEN
    Benign essential blepharospasm (BEB) is a focal dystonia that causes involuntary occlusion of the eyelids as result of bilateral contraction of orbicularis oculi muscle. A 51-year-old female patient evaluated at the outpatient clinic with complaints of contraction and closure of the left eye for about 11 years and the same complaints of light cyc for 10 years. Cranial magnetic resonance imaging was normal and blepharospasm was diagnosed based on the clinical and neurological evaluation. The patient underwent a botulinum toxin-A injection and was called for control 2 weeks later. BEB is a disease that seriously affects the quality of life of the patient, sometimes it can cause functional blindness. The time between diagnosis and treatment may be delayed in atypical cases. For this reason; differential diagnoses of atypical cases should be done well.
  • PublicationOpen Access
    Treatment of Motor Symptoms in Idiopathic Parkinson-s Disease
    (2015-08-01T00:00:00Z) Gokcal, Elif; BABACAN YILDIZ, GÜLSEN; GÖKÇAL, ELİF; BABACAN YILDIZ, GÜLSEN
    Idiopathic Parkinson-s disease is one of the most common neurodegenerative disorders. Idiopathic Parkinson-s disease continues to be a progressive disorder leading to severe disability caused by motor and non-motor symptoms. To date, there have been no disease-modifying or neuroprotective interventions that could stop or slow down disease progression. Treatment of motor symptoms, such as tremor, rigidity, and bradykinesia, is primarily focused on correcting dopamine deficiency. There are some medications that do not directly affect the dopaminergic system. Some invasive interventions are also available. Treatment options should be specified according to age, disease stage, functional status, and concurrent diseases of the patients. Non-motor symptoms, such as sleep disturbances and neuropsychiatric symptoms, should also be properly diagnosed and treated. This review focuses on treatment strategies for the motor symptoms of idiopathic Parkinson-s disease.
  • PublicationOpen Access
    Altered gut microbiota in patients with idiopathic Parkinson’s disease: an age–sex matched case–control study
    (2023-01-01) Babacan Yildiz G.; Kayacan Z. C.; KARACAN İ.; SÜMBÜL B.; Elibol B.; Gelisin O.; Akgul O.; BABACAN YILDIZ, GÜLSEN; SÜMBÜL, BİLGE; GELİŞİN, ÖZLEM
    Objective: The investigations related to how gut microbiota changes the brain-gut axis in idiopathic Parkinson's disease (PD) attract growing interest. We aimed to determine whether gut microbiota is altered in PD patients and whether non-motor symptoms of PD and disease duration had any relation with alterations of microbiota profiles among patients. Methods: Microbial taxa in stool samples obtained from 84 subjects (42-PD patients and 42-healthy spouses) were analyzed using 16S rRNA amplicon-sequencing. Results: We observed a significant decrease of Firmicutes and a significant increase of Verrucomicrobiota at the phylum level. At the family level, Lactobacillaceae and Akkermansiaceae were significantly increased and Coriobacteriales Incertae Sedis were significantly decreased in the PD patients compared to their healthy spouses. Genus level comparison inferred significant increase in abundance only in Lactobacillus while the abundance of Lachnospiraceae ND3007 group, Tyzzerella, Fusicatenibacter, Eubacterium hallii group and Ruminococcus gauvreauii group were all decreased. We determined that the abundance of Prevotella genus decreased, but not significantly in PD patients. In addition, we found differences in microbiota composition between patients with and without non-motor symptoms. Conclusion: We observed differences in gut microbiota composition between PD patients and their healthy spouses. Our findings suggest that disease duration influenced microbiota composition, which in turn influenced development of non-motor symptoms in PD. This study is the first in terms of both gut microbiota research in Turkish PD patients and the probable effect of microbiota on non-motor symptoms of PD.